533 related articles for article (PubMed ID: 18075269)
1. Intravenous polyclonal human immunoglobulins in multiple sclerosis.
Soelberg Sorensen P
Neurodegener Dis; 2008; 5(1):8-15. PubMed ID: 18075269
[TBL] [Abstract][Full Text] [Related]
2. Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trials.
Sørensen PS
Neurol Sci; 2003 Oct; 24 Suppl 4():S227-30. PubMed ID: 14598048
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
Humle Jorgensen S; Sorensen PS
J Neurol Sci; 2005 Jun; 233(1-2):61-5. PubMed ID: 15949496
[TBL] [Abstract][Full Text] [Related]
4. High-dose intravenous immunoglobulin treatment of multiple sclerosis.
Durelli L; Isoardo G
Neurol Sci; 2002 Apr; 23 Suppl 1():S39-48. PubMed ID: 12032586
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin in MS: promise or failure?
Fazekas F; Strasser-Fuchs S; Hommes OR
J Neurol Sci; 2007 Aug; 259(1-2):61-6. PubMed ID: 17449063
[TBL] [Abstract][Full Text] [Related]
6. [Intravenous immunoglobulins (IVIg) in the treatment of multiple sclerosis].
Achiron A; Miron S
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S41-4. PubMed ID: 10896988
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
Pöhlau D; Przuntek H; Sailer M; Bethke F; Koehler J; König N; Heesen C; Späth P; Andresen I
Mult Scler; 2007 Nov; 13(9):1107-17. PubMed ID: 17623736
[TBL] [Abstract][Full Text] [Related]
8. [Intravenous immunoglobulin in multiple sclerosis].
Ota K
Nihon Rinsho; 2003 Aug; 61(8):1374-80. PubMed ID: 12962026
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial.
Achiron A; Kishner I; Sarova-Pinhas I; Raz H; Faibel M; Stern Y; Lavie M; Gurevich M; Dolev M; Magalashvili D; Barak Y
Arch Neurol; 2004 Oct; 61(10):1515-20. PubMed ID: 15477504
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
Fazekas F; Lublin FD; Li D; Freedman MS; Hartung HP; Rieckmann P; Sørensen PS; Maas-Enriquez M; Sommerauer B; Hanna K; ;
Neurology; 2008 Jul; 71(4):265-71. PubMed ID: 18645164
[TBL] [Abstract][Full Text] [Related]
11. Long term safety of IVIg therapy in multiple sclerosis: 10 years experience.
Katz U; Kishner I; Magalashvili D; Shoenfeld Y; Achiron A
Autoimmunity; 2006 Sep; 39(6):513-7. PubMed ID: 17060031
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immune globulin in multiple sclerosis: clinical and neuroradiological results and implications for possible mechanisms of action.
Achiron A; Barak Y; Goren M; Gabbay U; Miron S; Rotstein Z; Noy S; Sarova-Pinhas I
Clin Exp Immunol; 1996 May; 104 Suppl 1():67-70. PubMed ID: 8625547
[TBL] [Abstract][Full Text] [Related]
13. The role of intravenous immunoglobulin in the treatment of multiple sclerosis.
Sorensen PS
J Neurol Sci; 2003 Feb; 206(2):123-30. PubMed ID: 12559498
[TBL] [Abstract][Full Text] [Related]
14. The Austrian Immunoglobulin in MS (AIMS) study: final analysis.
Strasser-Fuchs S; Fazekas F; Deisenhammer F; Nahler G; Mamoli B
Mult Scler; 2000 Oct; 6 Suppl 2():S9-13. PubMed ID: 11188778
[TBL] [Abstract][Full Text] [Related]
15. MRI as an outcome in multiple sclerosis clinical trials.
Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin therapy prevents development of autoimmune encephalomyelitis and suppresses activation of matrix metalloproteinases.
Niimi N; Kohyama K; Kamei S; Matsumoto Y
Neuropathology; 2011 Aug; 31(4):392-400. PubMed ID: 21175863
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis].
Cazzato G; Antonello RM; Zorzon M; Torre P; Zivadinov R; Moretti R; Bragadin LM; De Masi R; Nasuelli D
Recenti Prog Med; 1999 Oct; 90(10):538-44. PubMed ID: 10592740
[TBL] [Abstract][Full Text] [Related]
18. The effect on MRI of gammaglobulin treatment in relapsing multiple sclerosis.
Sørensen PS
Mult Scler; 2000 Oct; 6 Suppl 2():S14-7. PubMed ID: 11188772
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and treatment of multiple sclerosis. Update, 2003].
Jarius S; Hohlfeld R; Voltz R
MMW Fortschr Med; 2003 May; 145 Suppl 2():88-91, 93, 95. PubMed ID: 14579493
[TBL] [Abstract][Full Text] [Related]
20. Copolymer-1.
Comi G; Moiola L
Baillieres Clin Neurol; 1997 Oct; 6(3):495-509. PubMed ID: 10101586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
